JASMINE WILCOX: Open Payments
NPI 1346991478 · NEW PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,033 in 52 payments from 21 companies in 2025. Trend: 2023 $46 · 2024 $1,838 · 2025 $2,033
Long term medical supply or device loan: $1,097Food & beverage: $843Education: $93
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $1,258 |
| Lilly USA, LLC | 4 | $109 |
| SEAGEN INC. | 1 | $93 |
| PFIZER INC. | 6 | $79 |
| TerSera Therapeutics LLC | 2 | $67 |
| Stemline Therapeutics Inc. | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| JAZZ PHARMACEUTICALS INC. | 2 | $39 |
| Genentech USA, Inc. | 1 | $35 |
| Janssen Biotech, Inc. | 2 | $32 |
Products named: KISQALI, VERZENIO, Zoladex, Orserdu, PLUVICTO, IBRANCE, XTANDI, ZEPZELCA.
Industry payments across FL — which companies pay providers there.
